Individual holder
HAZEN STANLEY L
US·9 granted patents·6 pending applications·21 citations·filing 2006–2014
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
15 records- 0184US8338110B2Risk markers for cardiovascular diseaseHAZEN STANLEY L·Filed 2010·Granted Dec 25, 2012·8 cites·14 claims
- 0280US9140703B2Combined F2-isoprostane and myeloperoxidase detection, a risk indicator for cardiovascular diseaseHAZEN STANLEY L·Filed 2010·Granted Sep 22, 2015·2 cites·1 claims
- 0379US10241093B2Trimethylamine-containing compounds for diagnosis and prediction of diseaseHAZEN STANLEY L·Filed 2011·Granted Mar 26, 2019·4 cites·4 claims
- 0472US9423405B2Trimethylamine compounds as risk predictors of cardiovascular diseaseHAZEN STANLEY L·Filed 2008·Granted Aug 23, 2016·5 cites·20 claims
- 0570US8722344B2Risk markers for cardiovascular diseaseHAZEN STANLEY L·Filed 2012·Granted May 13, 2014·1 cites·9 claims
- 0670US8628935B2PON1 as a marker for heart failureHAZEN STANLEY L·Filed 2010·Granted Jan 14, 2014·1 cites·11 claims
- 0760US9365888B2Assessing the risk of a major adverse cardiac event in patients with chest painHAZEN STANLEY L·Filed 2012·Granted Jun 14, 2016·0 cites·9 claims
- 0859US9365889B2PON1 as a marker for heart failureHAZEN STANLEY L·Filed 2014·Granted Jun 14, 2016·0 cites·6 claims
- 0957US2011287449A1Myeloperoxidase, a risk indicator for cardiovascular diseaseHAZEN STANLEY L·Filed 2011·Application pending·0 cites
- 1051US2006211079A1Systemic markers for asthma and analogous diseasesHAZEN STANLEY L·Filed 2006·Application pending·0 cites
- 1149US9086425B2Carbamylated proteins and risk of cardiovascular diseaseHAZEN STANLEY L·Filed 2008·Granted Jul 21, 2015·0 cites·6 claims
- 1246US2012189612A1Compositions and methods for treating cancer while preventing or reducing cardiotoxicity and/or cardiomyopathyHAZEN STANLEY L·Filed 2012·Application pending·0 cites
- 1342US2011305707A1Compositions and methods for treating cancerHAZEN STANLEY L·Filed 2011·Application pending·0 cites
- 1442US2013280716A1Ratio of apoa2 to HDLc or Equivalents thereof, Risk Markers for Cardiovascular DiseaseHAZEN STANLEY L·Filed 2011·Application pending·0 cites
- 1540US2012164663A1Methylated Arginine Metabolites as Risk Predictors of Cardiovascular DiseaseHAZEN STANLEY L·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HAZEN STANLEY L files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →